Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hypertriglyceridemia
Comorbidity C0011847|diabetes
Sentences 21
PubMedID- 21532777 A survey conducted in >8000 patients receiving treatment for dyslipidaemia, (mostly with a statin) in 11 european countries confirmed a higher prevalence of low hdl-c and/or hypertriglyceridaemia in patients with type 2 diabetes, relative to patients without diabetes (table 1) [13, 14].
PubMedID- 25725623 The characteristic hypertriglyceridaemia observed in patients with type 2 diabetes stimulates cetp, leading to the preferential formation of triacylglycerol-rich small, dense ldl particles over larger ones [74].
PubMedID- 20398338 The nile rat fed typical rodent diets develops hyperinsulinemia that precedes hyperglycemia (insulin resistance) leading to diet-induced type 2 diabetes associated with hypertriglyceridemia, hypercholesterolemia, and hypertension.
PubMedID- 21477296 Among patients with type 2 diabetes the combination of abdominal enlargement and hypertriglyceridemia, so-called hypertriglyceridemic waist (hw), is highly prevalent [2] and has been associated with a greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes [3,4].
PubMedID- 23365565 In alloxan-induced diabetes, hyperglycemia is associated with hypertriglyceridemia and hypercholesterolemia [18].
PubMedID- 25035662 Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with diabetes mellitus.
PubMedID- 24164719 hypertriglyceridemia is commonly associated with diabetes, obesity, hypertension, and smoking, which are independent risk factors for chd [24,25].
PubMedID- 23734746 Background: postprandial hypertriglyceridemia in diabetes mellitus can be followed by endothelial dysfunction, impaired vascular compliance and increased cardiovascular complications.
PubMedID- 20537932 Conclusion: there was a significant discordance between ldl and non-hdl cholesterol levels in diabetes patients with high triglycerides or the ms.
PubMedID- 25573251 Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridaemia in patients with type 2 diabetes mellitus20.
PubMedID- 20722684 Severe hypertriglyceridaemia is associated with uncontrolled diabetes, obesity and poor physical activity.
PubMedID- 25617537 This literature review discusses the safety on glucose metabolism of n-3 pufa supplementation in the treatment of hypertriglyceridemia in subjects with type 2 diabetes mellitus.
PubMedID- 23408779 The most common dyslipidemia in diabetes is the combination of high triglycerides and low hdl levels.
PubMedID- 22224930 Even though insulin resistance, cardiovascular disease (cvd), and type 2 diabetes (t2d) are associated with hypertriglyceridemia, blacks with these conditions usually have normal triglyceride (tg) levels.
PubMedID- 21630032 Moreover, because hypertriglyceridemia is often associated with obesity, diabetes, metabolic syndrome, increased cholesterol levels, disturbed hemostasis and inflammation, some researchers assume that elevated triglyceride levels may be only a non-causal biomarker of future cardiovascular risk [7].
PubMedID- 21510110 Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease.
PubMedID- 22675253 Recent findings indicate that apoa5 could also influence cholesterol homeostasis and probably play a role in hypertriglyceridemia associated with diabetes and inflammation [20].
PubMedID- 23853615 Raised tg levels, small low density lipoprotein-cholesterol (ldl-c) particles, and low hdl-c (22)); low hdl-c was a component of mets only in the presence of hypertriglyceridemia in patients with type 2 diabetes mellitus (10).
PubMedID- 24684850 Recent findings indicate that apoa5 could also influence cholesterol homeostasis and probably could play a role in hypertriglyceridemia associated with diabetes and inflammation [11].
PubMedID- 24876549 Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridemia in patients with type 2 diabetes mellitus.
PubMedID- 26291068 Decreased vldl-apo b 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy.

Page: 1